Guus Hateboer
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- DNA Repair Mechanisms
- Genomics and Chromatin Dynamics
Papers in
-
- Epigenetics and DNA Methylation 5
- Ubiquitin and proteasome pathways 3
- Viral Infectious Diseases and Gene Expression in Insects 2
- RNA modifications and cancer 2
- Oncology 7
- Cancer-related Molecular Pathways 6
- Co-authors
- René Bernards (5 shared papers)Анна Шварц (2 shared papers)Elena Vigo (3 shared papers)Kristian Helin (2 shared papers)Roderick L. Beijersbergen (2 shared papers)Ron Kerkhoven (2 shared papers)Nicole Riteco (1 shared paper)A.J. van der Eb (1 shared paper)
- Journals
- Journal of Biological Chemistry (2 papers)The EMBO Journal (2 papers)Molecular and Cellular Biology (2 papers)Biotechnology and Bioengineering (1 paper)FEBS Letters (1 paper)
- Partner nations
- NetherlandsItalyFrance
In The Last Decade
Guus Hateboer
12 papers receiving 1.7k citations
Guus Hateboer's Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 974
- Molecular Biology 1.4k
- Biotechnology 150
- Cancer Research 166
- Cell Biology 194
Countries citing papers authored by Guus Hateboer
This map shows the geographic impact of Guus Hateboer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guus Hateboer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guus Hateboer more than expected).
Fields of papers citing papers by Guus Hateboer
This network shows the impact of papers produced by Guus Hateboer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guus Hateboer. The network helps show where Guus Hateboer may publish in the future.
Co-authors
The 25 scholars most cited alongside Guus Hateboer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | MDMX: a novel p53‐binding protein with some functional properties of MDM2. Hit paper breakdown → | 1996 | 522 |
| 2 | 1999 | 286 | |
| 3 | 1996 | 187 | |
| 4 | 1998 | 158 | |
| 5 | 1993 | 132 | |
| 6 | 1991 | 122 | |
| 7 | 1997 | 114 | |
| 8 | 1995 | 72 | |
| 9 | 1996 | 66 | |
| 10 | 2007 | 32 | |
| 11 | Cell Cycle-Regulated Expression of Mammalian CDC6 Is Dependent on E2F | 1998 | 12 |
| 12 | 1992 | 11 |
About Guus Hateboer
Guus Hateboer is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Virology, having authored 12 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Epigenetics and DNA Methylation (5 papers), Virus-based gene therapy research (4 papers), Ubiquitin and proteasome pathways (3 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), interferon and immune responses (2 papers), RNA modifications and cancer (2 papers) and Genetics and Neurodevelopmental Disorders (1 paper). The work is most often cited by research in Oncology (974 citations), Molecular Biology (1.4k citations), Biotechnology (150 citations), Cancer Research (166 citations) and Cell Biology (194 citations). Guus Hateboer has collaborated with scholars based in Netherlands, Italy and France. Frequent co-authors include René Bernards, Анна Шварц, Elena Vigo, Kristian Helin, Roderick L. Beijersbergen, Ron Kerkhoven, Nicole Riteco, A.J. van der Eb, Merlijn Bazuine and Aart G. Jochemsen. Their work appears in journals such as Journal of Biological Chemistry, The EMBO Journal, Molecular and Cellular Biology, Biotechnology and Bioengineering and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.